AI assistant
Sending…
Cardiff Oncology, Inc. — Director's Dealing 2021
Mar 4, 2021
33967_dirs_2021-03-04_413055b1-3ec5-43d9-a8fe-e47096182ae6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardiff Oncology, Inc. (CRDF)
CIK: 0001213037
Period of Report: 2021-03-04
Reporting Person: PACE GARY W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-04 | Common Stock | P | 1500 | $9.265 | Acquired | 451811 | Direct |
More from Cardiff Oncology, Inc.
Investor Presentation
2026
Jun 3
Legal Proceedings Report
2026
May 29
Legal Proceedings Report
2026
May 19
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 14
Board/Management Information
2026
Apr 9
Investor Presentation
2026
Feb 25
Earnings Release
2026
Feb 24
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 18